drugset / Trial / NCT01201694
Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)
Phase 1
Completed
28 enrolled
M.D. Anderson Cancer Center
Gateway for Cancer Research · collabTheravalues, Inc. · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to find the highest tolerable doses of surface-controlled water dispersible curcumin (curcumin) that can be given to patients with advanced cancer. The safety of this drug will also be studied.
Timeline
- Start
- 2011-10
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Curcumin | Small molecule | 100 mg | Oral |